BioSpace News Archive

ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Carl Firth, CEO, will participate in a fireside chat at the Jefferies Global Healthcare Conference.

Revive Therapeutics Advances Inflammatory Liver Disorders Programs for Autoimmune Hepatitis and Liver Transplantation.

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the presentation of five-year data from the M6-C ™ artificial cervical disc single-level IDE study.

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, announced the completion of enrollment of its Phase 1 (Ph1), open-label trial of pluripotent.

Brooklyn ImmunoTherapeutics, Inc . today announced the appointment of Matt Angel, Ph.D., Co-Founder, Chairman, and CEO of Factor Bioscience Inc., as Interim Chief Executive Officer and President.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date to December 28, 2022, for the Biologics License Application (BLA) for ublituximab as a treatment for patients with relapsing forms of multiple sclerosis (RMS).

Massachusetts-based biotech Conagen announces the development of a new scalable natural compound, dihydro resveratrol, for use in industrial and human health applications.

Eledon Pharmaceuticals, Inc. announced topline results from a Phase 2a clinical trial of tegoprubart in patients with amyotrophic lateral sclerosis.

Innodem Neurosciences is proud to announce that its novel mobile eye tracking technology for people living with multiple sclerosis has been granted “Breakthrough Device” designation by the U.S. Food & Drug Administration.

BioAge Labs, Inc. announced that Kristen Fortney, PhD, CEO and Co-Founder of BioAge, will lead a panel discussion at the BIO International Conference held June 13–16, 2022 in San Diego, California.